BREAKING: Moderna on Thursday asked U.S. regulators to authorize low doses of its COVID-19 vaccine for children younger than 6, a long-awaited move toward potentially opening shots for millions of tots by summer.
FILE - A health worker administers a dose of a Moderna COVID-19 vaccine during a vaccination clinic in Norristown, Pa., Tuesday, Dec. 7, 2021. Moderna on Thursday, April 28, 2022, asked U.S. regulators to authorize low doses of its COVID-19 vaccine for children younger than 6, a long-awaited move toward potentially opening shots for millions of tots by summer.Moderna on Thursday asked U.S.
“There is an important unmet medical need here with these youngest kids,” Dr. Paul Burton, Moderna's chief medical officer, told The Associated Press. Two kid-size shots “will safely protect them. I think it is likely that over time they will need additional doses. But we're working on that.” Whether it’s one company’s shots or both, FDA vaccine chief Dr. Peter Marks said the agency will “move quickly without sacrificing our standards” in deciding if tot-sized doses are safe and effective.
If FDA clears vaccinations for the littlest, next the Centers for Disease Control and Prevention would have to recommend who needs them -- all tots or just those at higher risk from COVID-19.“We’ve been kind of left behind as everybody else moves on,” said Meagan Dunphy-Daly, a Duke University marine biologist whose 6-year-old daughter is vaccinated -- but whose 3-year-old and 18-month-old sons are part of Pfizer’s trial.
Some parents even have urged the government to let families choose shots before all the evidence is in. Another issue: So far in the U.S., Moderna's vaccine is restricted to adults. Other countries have expanded the shot to kids as young as 6. But months ago the FDA cited concern about a rare side effect, heart inflammation, in teen boys, and it hasn't ruled on Moderna's earlier pediatric applications.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Moderna to ask FDA to authorize Covid-19 vaccine for young kidsThe request comes a month after the drug company signaled its two-dose regimen generated immune protection in the youngest children comparable to young adults.
続きを読む »
Moderna Asks FDA to Approve Its COVID-19 Shot for Kids Under 6Moderna on Thursday asked U.S. regulators to authorize low doses of its COVID-19 vaccine for children younger than 6, a long-awaited move toward potentially opening shots for millions of tots by summer.
続きを読む »
Moderna asks FDA to authorize first COVID-19 vaccine for very young childrenThe company says a low-dose version of its vaccine triggers an immune response in children ages 6 months to less than 6 years equivalent to what has protected older children and adults.
続きを読む »
Moderna Asks FDA to Clear Its Covid-19 Vaccine for Young ChildrenModerna asked the FDA to authorize its Covid-19 vaccine for children 6 months to 5 years. If regulators agree, vaccinations could begin by summer.
続きを読む »
Administration expands availability of COVID-19 antiviral pillPresident Joe Biden’s administration is taking steps to expand availability of the life-saving COVID-19 antiviral treatment Paxlovid.
続きを読む »
Beijing enforces lockdowns, expands COVID-19 mass testing amid outbreakResidents lined up for throat swabs across Beijing as mass testing was expanded to 11 city districts. Beijing has a total of 92 virus cases since an outbreak was discovered five days ago.
続きを読む »